The anticancer effect and mechanism of α-hederin on breast cancer cells

International Journal of Oncology

Volumn 45, Issue 2, 2014, Pages 757-763

  Cheng, Lin ^a   Xia, Tian Song ^a   Wang, Yi Fen ^c   Zhou, Wenbin ^a   Liang, Xiu Qing ^a   Xue, Jin Qiu ^a   Shi, Liang ^a   Wang, Ying ^a   Ding, Qiang ^a   Wang, Minhai ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b WANNAN MEDICAL COLLEGE   (China)

^c KUNMING INSTITUTE OF BOTANY   (China)

Author keywords

Apoptosis; Breast cancer; Mechanism; Mitochondria; hederin

Indexed keywords

ALPHA HEDERIN; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 3; CASPASE 9; CYTOCHROME C; ANTINEOPLASTIC AGENT; OLEANOLIC ACID; PLANT EXTRACT; SAPONIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN SECRETION; ANALOGS AND DERIVATIVES; BREAST TUMOR; CELL PROLIFERATION; CLEMATIS; DRUG EFFECTS; FLOW CYTOMETRY; METABOLISM; PATHOLOGY; PHYTOTHERAPY; PROCEDURES; TUMOR CELL LINE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CLEMATIS; FLOW CYTOMETRY; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; OLEANOLIC ACID; PHYTOTHERAPY; PLANT EXTRACTS; SAPONINS;

EID: 84902581576     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2449     Document Type: Article

References (35)

1. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin 63: 11-30, 2013.
2. Ribeiro JT, Macedo LT, Curigliano G, et al: Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: back to the future? Ann Oncol 23: 547-555, 2012.
3. Karikas GA: Anticancer and chemopreventing natural products: some biochemical and therapeutic aspects. J BUON 15: 627-638, 2010.
4. Cragg GM and Newman DJ: Natural products: a continuing source of novel drug leads. Biochim Biophys Acta 6: 18, 2013.
5. Wang TH, Wang HS and Soong YK: Paclitaxel-induced cell death: Where the cell cycle and apoptosis come together. Cancer 88: 2619-2628, 2000.
6. Ding Q, Yang LX, Yang HW, Jiang C, Wang YF and Wang S: Cytotoxic and antibacterial triterpenoids derivatives from Clematis ganpiniana. J Ethnopharmacol 126: 382-385, 2009.
7. Podolak I, Galanty A and Sobolewska D: Saponins as cytotoxic agents: a review. Phytochem Rev 9: 425-474, 2010.
8. Augustin JM, Kuzina V, Andersen SB and Bak S: Molecular activities, biosynthesis and evolution of triterpenoid saponins. Phytochemistry 72: 435-457, 2011.
9. Bishayee A, Ahmed S, Brankov N and Perloff M: Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer. Front Biosci (Landmark Ed) 16: 980-996, 2011.
10. Patlolla JMR and Rao CV: Triterpenoids for cancer prevention and treatment: Current status and future prospects. Curr Pharm Biotechnol 13: 147-155, 2012.
11. Calabrese AI: Letter: Antiviral activity of hederin. J Pharm Sci 64: VIII, 1975.
12. Gepdiremen A, Mshvildadze V, Suleyman H and Elias R: Acute anti-inflammatory activity of four saponins isolated from ivy: alpha-hederin, hederasaponin-C, hederacolchiside-E and hederacolchiside-F in carrageenan-induced rat paw edema. Phytomedicine 12: 440-444, 2005. (Pubitemid 40755118)
13. Gulcin I, Mshvildadze V, Gepdiremen A and Elias R: Antioxidant activity of saponins isolated from ivy: alpha-hederin, hederasaponin-C, hederacolchiside-E and hederacolchiside-F. Planta Med 70: 561-563, 2004. (Pubitemid 38887915)
14. Ridoux O, Di Giorgio C, Delmas F, et al: In vitro antileishmanial activity of three saponins isolated from ivy, alpha-hederin, beta-hederin and hederacolchiside A(1), in association with pentamidine and amphotericin B. Phytother Res 15: 298-301, 2001. (Pubitemid 32613096)
15. Trute A, Gross J, Mutschler E and Nahrstedt A: In vitro antispasmodic compounds of the dry extract obtained from Hedera helix. Planta Med 63: 125-129, 1997. (Pubitemid 27196078)
16. Quetin-Leclercq J, Elias R, Balansard G, Bassleer R and Angenot L: Cytotoxic activity of some triterpenoid saponins. Planta Med 58: 279-281, 1992.
17. Danloy S, Quetin-Leclercq J, Coucke P, et al: Effects of alpha-hederin, a saponin extracted from Hedera helix, on cells cultured in vitro. Planta Med 60: 45-49, 1994.
18. Rooney S and Ryan MF: Effects of alpha-hederin and thymoquinone, constituents of Nigella sativa, on human cancer cell lines. Anticancer Res 25: 2199-2204, 2005. (Pubitemid 40904623)
19. Tian Z, Liu YM, Chen SB, et al: Cytotoxicity of two triterpenoids from Nigella glandulifera. Molecules 11: 693-699, 2006. (Pubitemid 44492707)
20. Yan LH, Xu LZ, Lin J, Yang SL and Feng YL: Triterpenoid saponins from the stems of Clematis parviloba. J Asian Nat Prod Res 11: 332-338, 2009.
21. Kumara SS and Huat BT: Extraction, isolation and characterisation of antitumor principle, alpha-hederin, from the seeds of Nigella sativa. Planta Med 67: 29-32, 2001. (Pubitemid 32199941)
22. Feller G, Kugel A, Moonshine D, et al: African descents are more sensitive than European descents to the antitumor compounds alpha-hederin and kalopanaxsaponin I. Planta Med 76: 1847-1851, 2010.
23. Pasi S, Aligiannis N, Pratsinis H, Skaltsounis AL and Chinou IB: Biologically active triterpenoids from Cephalaria ambrosi-oides. Planta Med 75: 163-167, 2009.
24. Swamy SM and Huat BT: Intracellular glutathione depletion and reactive oxygen species generation are important in alpha-hederin-induced apoptosis of P388 cells. Mol Cell Biochem 245: 127-139, 2003. (Pubitemid 36416829)
25. Rooney S and Ryan MF: Modes of action of alpha-hederin and thymoquinone, active constituents of Nigella sativa, against HEp-2 cancer cells. Anticancer Res 25: 4255-4259, 2005. (Pubitemid 41665213)
26. Liu JJ, Lin M, Yu JY, Liu B and Bao JK: Targeting apoptotic and autophagic pathways for cancer therapeutics. Cancer Lett 300: 105-114, 2011.
27. Shi Y: Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 9: 459-470, 2002.
28. Dias N and Bailly C: Drugs targeting mitochondrial functions to control tumor cell growth. Biochem Pharmacol 70: 1-12, 2005. (Pubitemid 40797865)
29. Suen DF, Norris KL and Youle RJ: Mitochondrial dynamics and apoptosis. Genes Dev 22: 1577-1590, 2008. (Pubitemid 351846838)
30. Wang QF, Chen JC, Hsieh SJ, Cheng CC and Hsu SL: Regulation of Bcl-2 family molecules and activation of caspase cascade involved in gypenosides-induced apoptosis in human hepatoma cells. Cancer Lett 183: 169-178, 2002.
31. Wang J, Zhao XZ, Qi Q, et al: Macranthoside B, a hederagenin saponin extracted from Lonicera macranthoides and its anti-tumor activities in vitro and in vivo. Food Chem Toxicol 47: 1716-1721, 2009.
32. Park HM, Kim SJ, Kim JS and Kang HS: Reactive oxygen species mediated ginsenoside Rg3- and Rh2-induced apoptosis in hepatoma cells through mitochondrial signaling pathways. Food Chem Toxicol 50: 2736-2741, 2012.
33. Chun J, Ha IJ and Kim YS: Antiproliferative and apoptotic activities of triterpenoid saponins from the roots of Platycodon grandiflorum and their structure-activity relationships. Planta Med 79: 639-645, 2013.
34. Mo S, Xiong H, Shu G, et al: Phaseoloideside E, a novel natural triterpenoid saponin identified from Entada phaseoloides, induces apoptosis in Ec-109 esophageal cancer cells through reactive oxygen species generation. J Pharmacol Sci 122: 163-175, 2013.
35. Wang CZ, Li XL, Wang QF, Mehendale SR, Fishbein AB, Han AH, Sun S and Yuan CS: The mitochondrial pathway is involved in American ginseng-induced apoptosis of SW-480 colon cancer cells. Oncol Rep 21: 577-584, 2009.